Services
[ Therapeutic Expertise ] [ Trials Management Services ] [ Early Development Services ] [ Late Phase Services ] [ Drug Safety Management ] [ Electronic Regulatory Submissions ]
PRA offers a broad array of services that encompass the entire spectrum
of clinical development, from filing of Investigational New Drug (IND) and
similar regulatory applications to product registration and post-marketing
studies on a global basis. Core services include:
- Drug development and regulatory strategy plans
- Phase I (first-time-in-man) clinical trials
- Phase II through IV multi-center (international) clinical trials
- Development and analysis of integrated global clinical databases
- Preparation and submission of regulatory filings in North America and
Europe
- Long-term drug safety programs
Page last updated:
19 June 2008
|
